-
hcup-us.ahrq.gov/toolssoftware/ccs/AppendixASingleDX.txt
January 01, 2024 - 1542 1543 1548 20917 2304 2305 2306 79670 79671 79672 79673 79674 79676 V1006
16 Cancer of liver … 5760 5761 5762 5763 5764 5765 5768 5769
7933
151 Other liver
-
hcup-us.ahrq.gov/reports/factsandfigures/facts_figures_2006.jsp
January 01, 2006 - Hospital stays for Hodgkin's disease, kidney cancer and liver cancer all increased by over 25 percent … of stomach
14
Cancer of the colon
15
Cancer of rectum and anus
16
Cancer of liver
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/ghbfx9e3A6jQEqVW26y8Jv
March 09, 2021 - emphysema,
infectious and inflammatory processes, masses, nodules, or cysts
of the kidney, breast, adrenal, liver … infectious and inflammatory
processes; and masses, nodules, or cysts of the kidney, breast,
adrenal, liver
-
integrationacademy.ahrq.gov/products/topic-briefs/polysubstance-use
February 01, 2025 - Alcohol Use Disorders Identification Test - Alcoholic Liver Disease. Washington DC:U.S.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/menopause_executive.pdf
March 01, 2015 - Spontaneous reports
of assumed herbal hepatotoxicity by black cohosh: is the liver-
unspecific Naranjo
-
digital.ahrq.gov/sites/default/files/docs/citation/r01hs015274-carayon-final-report-2009.pdf
January 01, 2009 - All CV surgery
patients and acute
MI/post
catheterization;
kidney, pancreas or
liver transplants
-
digital.ahrq.gov/sites/default/files/docs/citation/r01hs020909-dixon-final-report-2017.pdf
January 01, 2017 - only included test results data for a case
of hepatitis B but also corollary results on the patient's liver
-
digital.ahrq.gov/sites/default/files/docs/citation/r21hs023952-chrischilles-final-report-2018.pdf
January 01, 2018 - significant hepatic disease
including cirrhosis, chronic hepatitis B or C, or have current elevated liver
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/insulin-blood-sugar-2010_research-protocol.pdf
January 01, 2010 - insulin secretion from the pancreatic beta cells; insulin action at the
level of skeletal muscle, liver
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/medicare-medication-use_research.pdf
April 01, 2014 - comorbidities in
this population, since many types of cancer and less
common comorbidities such as liver
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-bleeding-risks-with-aspirin-use/aspirin-to-prevent-cardiovascular-disease-and-cancer-april-2016
April 11, 2016 - also examined data by relevant a priori subgroups: age, sex, race/ethnicity, comorbidities (diabetes, liver
-
effectivehealthcare.ahrq.gov/health-topics/blood-transfusion-and-donation
-
effectivehealthcare.ahrq.gov/health-topics/kidney-cysts
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/single-group-studies_white-paper.pdf
January 01, 2013 - For example, in
patients with end-stage liver disease, the natural history of disease is so well known
-
hcup-us.ahrq.gov/reports/methods/2006_1.pdf
January 01, 2006 - infarction, peptic ulcer
disease, congestive heart failure, cerebrovascular disease, hemiplegia, and severe liver
-
digital.ahrq.gov/sites/default/files/docs/publication/r18hs017067-kaushal-final-report-2011.pdf
January 01, 2011 - days)
Total cholesterol (6 weeks)
HDL cholesterol (6 weeks)
Thyroid stimulating hormone (6 weeks)
Liver
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/antiplatelet-treatment_research-protocol.pdf
November 22, 2011 - treatment (including bleeding events and other
adverse events such as gastrointestinal events and liver
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/psoriasis-chronic_research-protocol.pdf
January 10, 2012 - systemic therapies are contraindicated or cannot be tolerated; prophylaxis of organ rejection in
kidney, liver
-
digital.ahrq.gov/sites/default/files/docs/publication/uc1hs015339-aranaydo-final-report-2007.pdf
January 01, 2007 - example: a patient with
hepatitis has an automatic diagnosis alert on all meds metabolized by the liver
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/xt2Uhv4qyLUZ8o2HB_a4YQ
July 01, 2013 - Longer-term use of
ART regimens may increase the risk for cardiovascular and
bone disease, as well as liver